###begin article-title 0
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene
###end article-title 0
###begin title 1
Purpose
###end title 1
###begin p 2
###xml 121 126 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 402 411 402 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 445 454 442 448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 489 492 483 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">210</sub>
###xml 496 499 490 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">683</sub>
###xml 690 699 684 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 844 853 835 841 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 39 45 <span type="species:ncbi:9606">humans</span>
###xml 905 910 <span type="species:ncbi:9606">human</span>
Several inherited corneal disorders in humans result from mutations in the transforming growth factor beta induced gene (TGFBI), which encodes for the extracellular transforming growth factor beta induced protein (TGFBIp) that is one of the most abundant proteins in the cornea. We previously reported a significant amount of TGFBIp in plasma by immunoblotting using the only TGFBIp antiserum (anti-p68betaig-h3) available at that time (anti-p68betaig-h3 was generated against residues Val210-His683 of TGFBIp). This observation raised the possibility that a fraction of corneal TGFBIp may originate from the plasma. However, recent experiments in our laboratory indicated that the anti-p68betaig-h3 antiserum cross-reacts with an environmental protein contaminant. Therefore, we investigated the specificity of the originally utilized anti-p68betaig-h3 antiserum and re-evaluated the amount of TGFBIp in human plasma by immunoblotting using a new specific antiserum.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 65 74 65 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 192 197 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 212 213 209 210 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 264 267 261 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134</sub>
###xml 271 274 268 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">236</sub>
###xml 339 346 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 385 392 382 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 408 410 405 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 509 516 506 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 811 818 808 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 186 191 <span type="species:ncbi:9606">human</span>
###xml 339 346 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 385 392 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 457 464 <span type="species:ncbi:9986">rabbits</span>
###xml 681 686 <span type="species:ncbi:9606">human</span>
The observed cross-reactivity of the previously utilized anti-p68betaig-h3 antiserum was tested by immunoblotting and the antigen identity was determined by mass spectrometry. A part of human TGFBI encoding an NH2-terminal 11.4 kDa fragment of TGFBIp (residues Gly134-Ile236) was amplified by polymerase chain reaction (PCR) and cloned in E. coli. The TGFBIp fragment was expressed in E. coli, purified by Ni2+-affinity chromatography, and used to immunize rabbits to produce a specific antiserum (anti-TGFBIp134-236). To enhance the detection of possible TGFBIp in plasma by allowing a higher sample load, albumin and immunoglobulin G (IgG) were specifically depleted from normal human plasma by affinity chromatography. The presence of TGFBIp in plasma was investigated by immunoblotting using the anti-TGFBIp134-236 antiserum. Purified TGFBIp from porcine corneas was used for estimation of the TGFBIp detection limit.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 50 59 50 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 159 168 156 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 245 252 239 246 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 80 85 <span type="species:ncbi:9606">human</span>
###xml 432 437 <span type="species:ncbi:9606">human</span>
The previously utilized TGFBIp antiserum, anti-p68betaig-h3, cross-reacted with human keratin-1, a common environmental protein contaminant. Thus, the anti-p68betaig-h3 antiserum recognizes both TGFBIp and keratin-1. In contrast, the anti-TGFBIp134-236 antiserum reacted with TGFBIp but showed no indication of reactivity with other proteins in plasma. Using this antiserum, TGFBIp was not detected in crude or albumin/IgG-depleted human plasma and the detection limit of TGFBIp using immunoblotting was estimated to be 10 ng.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 695 700 695 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 162 167 <span type="species:ncbi:9606">human</span>
###xml 212 217 <span type="species:ncbi:9606">human</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
Our failure to detect TGFBIp in human plasma using a highly specific antiserum suggests that TGFBIp is not present in a physiologically relevant concentration in human plasma. The previous impression that normal human plasma contains a significant amount of TGFBIp by immunoblotting was due to the utilization of a less specific antiserum that recognizes both TGFBIp and human keratin-1. Together with other results, our observation makes it unlikely that TGFBIp is imported into the cornea from the circulation as reported for other abundant extracellular corneal proteins and suggests corneal origin of TGFBIp deposits in individuals with inherited corneal diseases caused by mutations in the TGFBI gene.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 279 284 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 306 311 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BIGH3</italic>
###xml 420 421 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 607 608 604 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 653 656 650 653 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">619</sub>
###xml 660 663 657 660 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">620</sub>
###xml 667 670 664 667 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">621</sub>
###xml 746 747 743 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 748 749 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 765 766 762 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r8">8</xref>
###xml 803 804 800 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 805 807 802 804 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 553 558 <span type="species:ncbi:9606">human</span>
The transforming growth factor beta induced protein (TGFBIp; also known as kerato-epithelin, beta ig-h3, betaig-h3, RGD-containing collagen-associated protein [RGD-CAP], and MP78/70) is an extracellular matrix protein encoded by the transforming growth factor beta induced gene (TGFBI; formerly designated BIGH3), which was first discovered in a lung adenocarcinoma cell line exposed to transforming growth factor beta [1]. The protein is composed of 683 residues including a 23-amino acid signal peptide. TGFBIp is highly conserved and the full-length human and porcine TGFBIp sequences are 93% identical [2]. TGFBIp contains an RGD motif (residues Arg619-Gly620-Asp621 in mature TGFBIp) and has been shown to interact with different integrins [3-7], fibronectin [8], collagen types I, II, IV, and VI [9,10] and to stimulate cell migration. Thus, the interaction of TGFBIp with these ligands suggests that TGFBIp plays a role in cell adhesion but its specific physiological role remains unclear.
###end p 10
###begin p 11
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 134 135 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 310 311 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 283 288 <span type="species:ncbi:9606">human</span>
The TGFBI gene is expressed in many tissues but TGFBIp is especially abundant in the cornea [11,12], skin [13], bone [14], cartilage [9], tendon [15], and kidney [16]. We discovered TGFBIp in the normal human cornea [12] and have recently purified and characterized the protein from human and porcine corneas [2]. Most of the corneal TGFBIp has a mature molecular mass of 68 kDa and migrates as an about 65 kDa protein in reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The corneal TGFBIp is truncated in the COOH-terminus immediately after the putative integrin-binding sequence (RDG) and most likely lacks posttranslational modifications. In addition, about 60% of the corneal TGFBIp is covalently associated with insoluble components.
###end p 11
###begin p 12
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r17">17</xref>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 622 629 <span type="species:ncbi:9606">patient</span>
Mutations in the TGFBI gene are associated with an accumulation of TGFBIp in several inherited corneal disorders that lead to impaired vision [17-19]. Some mutations result in an accumulation of amyloid within the corneal stroma [18,20,21] while others generate fuschinophilic crystalloid deposits in the cornea that are characteristics of the granular corneal dystrophies. Furthermore, the Arg124His mutation gives rise to a combination of granular and amyloid deposits while mutation Arg555Gln causes curly fibers characteristic of Thiel-Behnke dystrophy [18]. In a recent systemic investigation of TGFBIp deposits in a patient with lattice corneal dystrophy type I, deposits were not detected in any tissue except the cornea, suggesting a cornea-specific mechanism for the TGFBIp accumulations [22].
###end p 12
###begin p 13
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 406 415 406 412 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 418 420 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 630 632 627 629 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
###xml 769 771 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 882 887 879 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 1156 1158 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 1159 1161 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r32">32</xref>
###xml 273 279 <span type="species:ncbi:9606">person</span>
###xml 971 976 <span type="species:ncbi:9606">human</span>
The TGFBI gene is highly expressed in the corneal epithelium [11] and stromal cells [23], suggesting that wild-type and mutant TGFBIp are synthesized locally in normal and diseased corneas. However, significant amounts of TGFBIp have been reported in plasma from a healthy person and an individual with granular corneal dystrophy [24] using the only antiserum against TGFBIp available at the time (anti-p68betaig-h3) [25]. This suggested that at least some corneal TGFBIp may originate from plasma. That some corneal proteins are derived from the plasma is well established. Thus, bioinformatic comparison of the cornea proteome [26] with high quality gene expression data from the cornea strongly indicates that most plasma proteins are not synthesized in the cornea [27] but probably enter this tissue from neighboring blood vessels. The possibility that TGFBIp deposition in the TGFBI corneal disorders might be plasma derived was supported by the somewhat comparable human disease hypergammaglobulinemia. Immunoglobulin normally enters the cornea from plasma and in hypergammaglobulinemia, this protein sometimes aggregates and deposits in the cornea [28-32].
###end p 13
###begin p 14
###xml 51 60 51 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 223 225 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 308 317 305 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 570 577 564 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 170 175 <span type="species:ncbi:9606">human</span>
###xml 400 405 <span type="species:ncbi:9606">human</span>
###xml 677 682 <span type="species:ncbi:9606">human</span>
###xml 747 752 <span type="species:ncbi:9606">human</span>
However, recently we have noticed that the anti-p68betaig-h3 utilized to immunodetect TGFBIp in plasma reacted with another protein, raising doubt on the conclusion that human plasma contains significant amounts of TGFBIp [24]. We hence examined the specificity of the previously utilized antiserum, anti-p68betaig-h3. Here, we report that it is not only specific against TGFBIp but also reacts with human keratin-1, a common environmental protein contaminant having approximately the same molecular mass as TGFBIp. Using a new and highly specific antiserum (anti-TGFBIp134-236) for immunodetection of TGFBIp, we conclude that the previous strong detection of TGFBIp in normal human plasma was in error and that TGFBIp is not detectable in normal human plasma under the conditions tested. Thus, our results suggest that corneal TGFBIp is not imported into the cornea from plasma but originates from local synthesis in the cornea.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
###xml 34 35 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cloning and purification of the NH2-terminal transforming growth factor beta induced protein fragment
###end title 16
###begin p 17
###xml 10 11 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 67 70 67 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134</sub>
###xml 74 77 74 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">236</sub>
###xml 119 122 119 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">111</sub>
###xml 126 129 126 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">213</sub>
###xml 321 326 321 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 483 484 483 484 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 497 498 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 504 511 504 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 303 308 <span type="species:ncbi:9606">human</span>
###xml 504 511 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
A human NH2-terminal 11.4 kDa TGFBIp-fragment covering residues Gly134-Ile236 of the full-length precursor protein (Gly111-Ile213 of the mature protein) was cloned by PCR using forward primer 5'- CAC CGG GCC CGG CAG CTT CAC CAT CTT CG-3', reverse primer 5'-TCA GAT GAC CTT ATC GAT CGA TGA GGT G-3', and human full-length TGFBI cDNA as template. The resulting PCR product was inserted into the expression plasmid pET100/D-TOPO (Invitrogen, Taastrup, Denmark) thereby introducing an NH2-terminal His6-tag. E. coli strain TOP10F' (Invitrogen, Taastrup, Denmark) was transformed with the plasmid and the transformed cells were selected on Luria Broth (LB) medium/agar plates. The sequence of the insert was verified by DNA sequencing.
###end p 17
###begin p 18
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 24 26 24 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 785 787 767 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 986 987 968 969 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 0 7 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
E. coli strain BL21 StarTM (DE3) from Invitrogen (Taastrup, Denmark) was transformed with the plasmid and cultured in LB medium at 37 degreesC. Protein expression was induced by adding isopropyl-beta-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM and the cells were grown for two h. Cells were harvested by centrifugation, suspended in 40 ml Tris-buffered saline (TBS; 20 mM Tris-HCl, pH 7.6, and 137 mM NaCl) and lysed three times in a French press. The crude cell extract was centrifuged at 22,000x g for 30 min at 4 degreesC and the insoluble fraction was dissolved at 4 degreesC in 8 ml 20 mM Tris-HCl (pH 7.4), 10 mM imidazole, and 6 M guanidine, before being centrifuged at 16,000x g for 20 min. The resulting supernatant was filtered and loaded onto a HiTrap Ni2+-affinity column (Amersham Biosciences, Little Chalfont, England) and the column was washed thoroughly with 20 mM Tris-HCl (pH 7.4), 500 mM NaCl, 10 mM imidazole, and 6 M guanidine. The His-tagged NH2-terminal fragment of TGFBIp was eluted stepwise with 20, 40, 60, and 100 mM imidazole in the same buffer. Each fraction was dialyzed into 20 mM ammonium bicarbonate and precipitated proteins were analyzed by reduced SDS-PAGE. The 60 mM and 100 mM eluates were dried in a speed vac and resuspended in 50 mM Hepes (pH 7.4) and 100 mM NaCl.
###end p 18
###begin title 19
###xml 36 43 36 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
Production of antiserum (anti-TGFBIp134-236) and determination of detection limit
###end title 19
###begin p 20
###xml 84 85 83 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 200 207 199 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 361 362 359 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 0 7 <span type="species:ncbi:9986">Rabbits</span>
Rabbits were immunized five times subcutaneously with approximately 60 mug of the NH2-terminal TGFBIp-fragment per injection at four-week intervals. To determine the detection limit of the anti-TGFBIp134-236 antiserum, immunoblotting was performed with increasing amounts (2 ng-0.5 mug) of porcine corneal TGFBIp that had been purified as previously described [2].
###end p 20
###begin title 21
###xml 34 39 <span type="species:ncbi:9606">human</span>
Depletion of albumin and IgG from human plasma
###end title 21
###begin p 22
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
###xml 373 374 373 374 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 376 377 376 377 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 423 425 423 425 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TM</sup>
###xml 7 12 <span type="species:ncbi:9606">human</span>
Normal human plasma obtained from the Danish National Serum Institute, Copenhagen was depleted of albumin and IgG by affinity chromatograpy. First, albumin was depleted using agarose immobilized Anti-HSA Affibody molecule (Affibody AB, Bromma, Sweden) [33,34] following the manufacturer's recommended protocol. Secondly, the flow-through was diluted five times in 20 mM NaH2PO4 (pH 7.0) and applied to a Protein G SepharoseTM 4 Fast Flow resin (Amersham Biosciences, Little Chalfont, England) equilibrated in the same buffer. The flow-through was dialyzed into 10 mM ammonium bicarbonate, lyophilized in a speed vac, and dissolved in 20 mM Tris-HCl (pH 7.4) and 100 mM NaCl to a final volume equaling that of the crude plasma. The column materials used for the removal of albumin and IgG did not have affinity for TGFBIp (data not shown).
###end p 22
###begin title 23
SDS-polyacrylamide gel electrophoresis (SDS-PAGE)
###end title 23
###begin p 24
###xml 175 184 175 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 231 234 228 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">210</sub>
###xml 238 241 235 238 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">683</sub>
###xml 280 289 277 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 350 352 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 629 631 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
Blank samples containing SDS sample buffer and increasing amounts of dithiothreitol (DTT; 0-50 mM) were prepared and boiled to investigate the cross-reactivity of the anti-p68betaig-h3 antiserum directed against TGFBIp-fragment Val210-His683 of the precursor protein. The anti-p68betaig-h3 antiserum was the first antiserum generated against TGFBIp [25]. The plasma samples and purified corneal TGFBIp were boiled in SDS sample buffer containing 10 mM DTT. All samples were analyzed on 5-15% linear gradient gels (10x10x0.1 cm) using the 2-amino-2-methyl-1,3 propandiol (ammediol)/glycine/HCl buffer system as described by Bury [35].
###end p 24
###begin title 25
Immunoblotting
###end title 25
###begin p 26
###xml 501 510 501 507 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 522 524 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 569 576 566 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 601 602 598 599 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 397 403 <span type="species:ncbi:9986">rabbit</span>
###xml 422 427 <span type="species:ncbi:9606">human</span>
###xml 859 865 <span type="species:ncbi:9986">rabbit</span>
Following SDS-PAGE, proteins were electroblotted to a polyvinylidene difluoride (PVDF) membrane (Millipore Immobilon transfer membranes, Millipore, Bedford, MA) and analyzed by immunoblotting. The PVDF membranes were blocked in 30 ml 1% dry milk solution in Tris-buffered saline with 0.1% Tween (TBS-T; 20 mM Tris-HCl, pH 7.6, 137 mM NaCl, and 0.1% Tween) for one h at room temperature before the rabbit antiserum against human TGFBIp was added to the blocking solution. The previous utilized anti-p68betaig-h3 antiserum [24] was diluted 1:20,000, while the anti-TGFBIp134-236 antiserum against the NH2-terminal fragment of TGFBIp was diluted 1:2,000. After an overnight incubation with the primary antibody at 4 degreesC, the membrane was washed 3x15 min with TBS-T and then incubated for two h at room temperature in 60 ml of TBS-T containing 2 mul of anti-rabbit IgG peroxidase conjugate (Sigma Chemical Co., St. Louis, MO) and washed 3x15 min with TBS-T. Finally, the membranes were developed for one min using the enhanced chemiluminescence western blotting detection system and reagents (Amersham Biosciences, Little Chalfont, England). Purified TGFBIp from porcine corneas was used as a control.
###end p 26
###begin title 27
Collection and analysis of dust
###end title 27
###begin p 28
Normal environmental dust collected from three locations in the laboratory was pooled, and suspended in sample buffer containing 35 mM DTT to a final and absolute concentration of 50 mg/ml. The suspension was boiled for five min and centrifuged, then the supernatant (stock) was analyzed by SDS-PAGE.
###end p 28
###begin title 29
Protein visualization and identification by matrix-assisted laser desorption ionization mass spectrometry
###end title 29
###begin p 30
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r36">36</xref>
Proteins separated by SDS-PAGE were visualized by silver or coomassie brilliant blue staining as indicated. The protein bands of interest were excised and prepared for matrix-assisted laser desorption ionization mass spectrometry (MALDI) analysis as previously described for 2-D gel spots [36]. MALDI-time of flight mass spectrometry (MALDI-TOF MS) data was acquired using a Quadrupole-time of flight (Q-TOF) Ultima Global instrument (Micromass/Waters Corp., Manchester, United Kingdom) and the peak list of peptides were used to query all entries of the Swiss-Prot protein database on a local Mascot server using the Mascot search engine (Matrix Sciences, London, United Kingdom). The searches were performed with a peptide mass tolerance of 50 parts per million (ppm). Propionamide was selected as fixed modification of cysteine residues, and oxidation of methionine residues was selected as variable modification in the searches. In addition, a single missed tryptic cleavage was allowed. Only significant hits as defined by Mascot probability analysis were accepted.
###end p 30
###begin title 31
Results
###end title 31
###begin p 32
###xml 70 79 70 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 120 123 117 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">210</sub>
###xml 127 130 124 127 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">683</sub>
###xml 348 356 345 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 452 460 449 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 585 593 582 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 650 659 647 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 764 772 758 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 917 925 911 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 967 975 961 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 1041 1050 1035 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 1238 1246 1229 1237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
Recent observations in our laboratory have indicated that the anti-p68betaig-h3 antiserum generated against residues Val210-His683 of the precursor TGFBIp strongly reacts against another protein. Therefore, the specificity of this antiserum was analyzed by immunoblotting using sample buffer as blank samples with increasing concentrations of DTT (Figure 1, lanes 1-7). Using non-reducing conditions, the antiserum did not react with the blank sample (Figure 1, lane 1). However, the antiserum reacted strongly with a protein of about 65 kDa as the concentration of DTT was increased (Figure 1, lanes 2-7). In addition, the reactivity of the anti-p68betaig-h3 antiserum against samples containing TGFBIp was tested under both reducing and non-reducing conditions (Figure 1, lanes 8 and 9). As expected, the antiserum showed strong reactivity against a protein contaminant (about 65 kDa) in the presence of 35 mM DTT (Figure 1, lane 8). Under non-reducing conditions (Figure 1, lane 9) only TGFBIp (about 64 kDa) is recognized by the anti-p68betaig-h3 antiserum. Thus, this antiserum reacted strongly with a protein contaminant following reduction of disulfides, which also explains the apparent reaction with the molecular weight marker (Figure 1, lane 10).
###end p 32
###begin p 33
###xml 12 21 12 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 212 221 209 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 252 255 246 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">210</sub>
###xml 259 262 253 256 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">683</sub>
The anti-p68betaig-h3 antiserum shows strong reactivity with a protein-contaminant under reducing conditions. The immunoblot shows sample buffer as blank samples containing increasing amounts of DTT. The anti-p68betaig-h3 antiserum against residues Val210-His683 of the TGFBIp precursor was used in a dilution ratio of 1:20,000. Lanes 1-7 contain sample buffer with increasing amounts of DTT (0-50 mM). Lane 8 shows 0.16 mug of TGFBIp in sample buffer containing 35 mM DTT. Lane 9 shows 0.16 mug of TGFBIp in sample buffer in the absence of DTT. Lane 10 is the molecular weight standard.
###end p 33
###begin p 34
###xml 131 139 131 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 240 248 240 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 620 625 <span type="species:ncbi:9606">human</span>
To determine the identity and origin of the approximately 65 kDa contaminating protein recognized by the antiserum, blank samples (Figure 2, lanes 1-3) and normal environmental dust that was dissolved in sample buffer containing 35 mM DTT (Figure 2, lane 4) were separated by SDS-PAGE and the proteins were visualized by silver staining. Both the blank and dust samples contain two predominant proteins with molecular weights of 60 kDa and about 65 kDa. However, the protein bands were more intense in the lane with dissolved dust than in the blank samples. The 60 kDa and 65 kDa proteins were identified by MALDI-MS as human keratin-10 (Protein score: 119) and keratin-1 (Protein score: 93), respectively. Keratin-1 has a theoretical molecular weight of 66.1 kDa, while keratin-10 has a theoretical molecular weight of 59.8 kDa.
###end p 34
###begin p 35
Analysis and identification of the environmental protein contaminants. Silver stained SDS gel of blank and dust samples. Lanes 1-3 show blank samples containing sample buffer and 35 mM DTT. Lane 4 shows proteins extracted from 25 mug of normal environmental dust in sample buffer containing 35 mM DTT. The upper band (about 65 kDa) is keratin-1 and the lower band (60 kDa) is keratin-10.
###end p 35
###begin p 36
###xml 74 81 74 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 164 165 164 165 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 209 212 209 212 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">111</sub>
###xml 216 219 216 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">213</sub>
###xml 255 258 255 258 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134</sub>
###xml 262 265 262 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">236</sub>
###xml 322 329 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 391 398 391 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 454 456 454 456 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 543 551 543 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 322 329 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 391 398 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 581 588 <span type="species:ncbi:9986">rabbits</span>
Due to this observation, a new antiserum against human TGFBIp (anti-TGFBIp134-236) was produced to detect and determine the concentration of TGFBIp in plasma. An NH2-terminal fragment constituting residues Gly111-Ile213 of the mature protein (equaling Gly134-Ile236 of the full-length protein) was cloned and expressed in E. coli. The purification from the insoluble fraction of the induced E. coli cells was performed under denaturing conditions. The Ni2+-affinity chromatography resulted in a highly pure elution of the His-tagged fragment (Figure 3), which was used to immunize rabbits.
###end p 36
###begin p 37
###xml 30 31 30 31 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 75 76 75 76 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 115 118 115 118 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134</sub>
###xml 122 125 122 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">236</sub>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 201 203 201 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 144 151 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
Purification of recombinant NH2-terminal TGFBIp fragment. The His-tagged NH2-terminal TGFBIp-fragment (residues Gly134-Ile236) was expressed in E. coli and purified from the insoluble fraction using Ni2+-affinity chromatography. The step-wise elution was analyzed by SDS-PAGE and the gel was stained with coomassie brilliant blue. Lane 1 shows the eluate from elution buffer containing 40 mM imidazole. Lane 2 contains the eluate from 60 mM imidazole. Lane 3 contains the eluate from 100 mM imidazole. All lanes contain 50 mul of the elution.
###end p 37
###begin p 38
###xml 210 218 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 236 243 235 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 416 417 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 466 467 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 440 445 <span type="species:ncbi:9606">human</span>
To detect TGFBIp in human plasma, increasing amounts of normal crude plasma (1 nl-1 mul) were analyzed by immunoblotting following reducing SDS-PAGE. Purified TGFBIp from porcine corneas was used as a control (Figure 4). The anti-TGFBIp134-236 antiserum did not react with any proteins in crude plasma but did react with purified porcine TGFBIp. Thus, as expected from the high sequence identify (98%) between the NH2-terminal fragments of human and porcine TGFBIp [2], the TGFBIp antiserum recognized porcine TGFBIp.
###end p 38
###begin p 39
###xml 67 74 67 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 24 29 <span type="species:ncbi:9606">human</span>
###xml 135 140 <span type="species:ncbi:9606">human</span>
###xml 368 373 <span type="species:ncbi:9606">human</span>
Immunoblotting of crude human plasma using the specific anti-TGFBIp134-236 antiserum. The immunoblot shows increasing amounts of crude human plasma diluted in 20 mM Tris-HCl (pH 7.4) and 100 mM NaCl. Each lane contains 20 mul of diluted crude plasma. Lane 1 contains 0.2 mug of purified porcine TGFBIp was used as a control. Lanes 2-6 have increasing amounts of crude human plasma. The indicated volumes refer to the amount of crude plasma. Lane 7 is the molecular weight standard.
###end p 39
###begin p 40
###xml 39 41 39 41 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r38">38</xref>
###xml 563 571 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
Albumin (67 kDa) and IgG comprise 55% [37] and 10-25% [38] of the total plasma protein mass, respectively. Thus, depletion of albumin and IgG from plasma should remove 65-80% of the total protein content allowing larger volumes of plasma to be analyzed by SDS-PAGE. Consequently, this will enhance the detection of TGFBIp if present in plasma. The immunoblotting was repeated using increasing amounts of the albumin/IgG-depleted plasma preparation equaling 1-20 mul of crude plasma. Despite the high amounts of plasma loaded on the gel, no reaction was observed (Figure 5).
###end p 40
###begin p 41
###xml 82 89 82 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 39 44 <span type="species:ncbi:9606">human</span>
###xml 165 170 <span type="species:ncbi:9606">human</span>
###xml 349 354 <span type="species:ncbi:9606">human</span>
Immunoblotting of albumin/IgG-depleted human plasma using the specific anti-TGFBIp134-236 antiserum. The immunoblot shows increasing amounts of albumin/IgG-depleted human plasma in 20 mM Tris-HCl (pH 7.4) and 100 mM NaCl. Each lane contains 20 mul of diluted albumin/IgG-depleted plasma. Lanes 1-5 contain increasing amounts of albumin/IgG-depleted human plasma. The indicated volumes refer to the equaling amount of crude plasma. Lane 6 contains 0.2 mug of purified porcine TGFBIp, which was used as a control. Lane 7 is the molecular weight standard.
###end p 41
###begin p 42
###xml 28 29 28 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 183 191 183 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f6">Figure 6</xref>
###xml 330 338 330 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 780 781 779 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 254 259 <span type="species:ncbi:9606">human</span>
###xml 696 701 <span type="species:ncbi:9606">human</span>
The antiserum against the NH2-terminal fragment of human TGFBIp shows high specificity and its sensitivity was determined using increasing amounts of purified porcine corneal TGFBIp (Figure 6). In addition, increasing amounts of the albumin/IgG-depleted human plasma was analyzed on the same gel to verify the results depicted in Figure 5. The detection limit of TGFBIp using the present immunoblotting method was about 10 ng. Since no TGFBIp was detected in an albumin/IgG-depleted sample equaling 20 mul of crude plasma, the present results show that the concentration of TGFBIp in plasma is less than 0.5 mg/l. This estimation is based on the assumption that the antiserum reacts equally with human and porcine TGFBIp, which seems reasonable owing to the 98% identity of the NH2-terminal fragments of TGFBIp.
###end p 42
###begin p 43
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 245 250 <span type="species:ncbi:9606">human</span>
Detection limit of TGFBIp using purified porcine TGFBIp from corneas. The immunoblot shows increasing amounts of albumin/IgG-depleted human plasma and purified porcine TGFBIp (2-500 ng). Lanes 1-3 show increasing amounts of albumin/IgG-depleted human plasma. The indicated volumes refer to the equaling amount of crude plasma. Lanes 4-11 show increasing amounts of purified porcine TGFBIp. The amount of loaded porcine TGFBIp is indicated for each lane. The detection limit is about 10 ng TGFBIp. Lane 12 is the molecular weight standard.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 112 115 112 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">210</sub>
###xml 119 122 119 122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">683</sub>
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 354 363 354 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 598 607 595 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 942 944 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 1828 1830 1822 1824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r39">39</xref>
###xml 1889 1892 1883 1886 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">210</sub>
###xml 1896 1899 1890 1893 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">683</sub>
###xml 2266 2267 2260 2261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 2512 2521 2506 2512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;ig-h3</sup>
###xml 2743 2745 2734 2736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r40">40</xref>
###xml 2919 2921 2910 2912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 3045 3046 3036 3037 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 3265 3272 3256 3263 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">134-236</sup>
###xml 3785 3787 3776 3778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r37">37</xref>
###xml 3991 3993 3981 3983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r41">41</xref>
###xml 198 203 <span type="species:ncbi:9606">human</span>
###xml 246 253 <span type="species:ncbi:9606">patient</span>
###xml 677 682 <span type="species:ncbi:9606">human</span>
###xml 915 920 <span type="species:ncbi:9606">human</span>
###xml 947 952 <span type="species:ncbi:9606">Human</span>
###xml 1171 1176 <span type="species:ncbi:9606">human</span>
###xml 3184 3189 <span type="species:ncbi:9606">human</span>
###xml 3937 3945 <span type="species:ncbi:9606">patients</span>
In an earlier study using immunoblotting and a polyclonal antibody against a recombinant fragment of TGFBIp (Val210-His683), our laboratory reported the presence of significant amounts of TGFBIp in human plasma from both normal individuals and a patient suffering from granular corneal dystrophy [24]. However, the specificity of this antiserum, anti-p68betaig-h3, is now questioned as it reacts not only against TGFBIp but also with an environmental protein contaminant that is present even in blank samples only containing SDS sample buffer and DTT. In this study, we have shown that the anti-p68betaig-h3 antiserum is not specific for TGFBIp because it reacts strongly with human keratin-1 under reducing conditions. Unfortunately, keratin-1 migrates at the same position (about 65 kDa) as TGFBIp under reducing conditions indicating that the previous interpretation of finding a significant amount of TGFBIp in human plasma was in error [24]. Human keratins such as keratin-10 (59.8 kDa), keratin-9 (62.1 kDa), epidermal keratin-2 (65.9 kDa), and keratin-1 (66.1 kDa) are known to be common laboratory contaminants and an analysis by use of normal dust verified that human keratin-1 and -10 are indeed abundant in dust. Therefore, the trace amount of the keratin-10/1 pair in blank control samples probably originated from dust. Keratins are intermediate filament proteins forming approximately 10 nm cytoskeletal filaments that stabilize the structure of the cell. The keratin-10/1 pair is tissue-specific and mainly expressed in suprabasal differentiating keratinocytes within epidermis. Thus, keratin-1 and keratin-10 together with epidermal keratin-2 are characteristic of the post-mitotic upper layer of epidermis and therefore likely to end up in dust as the cornified and dead keratinocytes desquamate from the skin [39]. Since keratin-1 and the recombinant TGFBIp-fragment (Val210-His683 of TGFBIp) show no significant sequence similarity, it is very unlikely that antibodies will recognize both proteins through reactivity with shared epitopes. However, contamination of an antigen preparation with small amounts of dust prior to immunizations could lead to reactivity of the antiserum against keratin-1 in addition to TGFBIp. Since both mature TGFBIp [2] and keratin-1 migrate with molecular masses of about 65 kDa in reducing SDS-PAGE, reactivity against contaminating keratin-1 in immunoblotting is easily misinterpreted as detection of TGFBIp. The fact that we observe reactivity of the anti-p68betaig-h3 antiserum against keratin-1 only under reducing conditions is probably because all keratins of the cornified layer of epidermis are cross-linked by intermolecular disulfide bonds forming high molecular weight structures [40], which prevent the protein from entering the gel under non-reducing conditions. Thus, we conclude that the previous strong detection of TGFBIp in plasma by immunoblotting [24] was incorrect, demonstrating the importance of using direct protein identification methods such as mass spectrometry or NH2-terminal sequencing. Because of this we have produced a new antiserum against TGFBIp and reinvestigated the presence of TGFBIp in normal human plasma with the aim of determining its concentration. With this anti-TGFBIp134-236 antiserum, which showed no indications of reactivity with other proteins, we could not detect TGFBIp in normal crude plasma or in plasma depleted of albumin and IgG under the conditions tested. Based on the detection limit, which was estimated using purified TGFBIp from porcine corneas, we conclude that the concentration of TGFBIp in plasma is below 0.5 mg/l, which is in the range of so-called tissue leakage proteins caused, for example, by tissue turnover and thus with no physiological function in plasma [37]. Thus, our observation is consistent with another study reporting the detection of TGFBIp in the mug/ml range in serum from healthy individuals and patients with colorectal cancer using an ELISA assay [41].
###end p 45
###begin p 46
###xml 168 173 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBI</italic>
The present evidence against a plasma derived origin for corneal TGFBIp has implications for the pathogenesis of inherited corneal disorders caused by mutations in the TGFBI gene. It suggests that corneal TGFBIp deposits in individuals with mutations in the TGFBI gene originate from local synthesis in the cornea rather than from the plasma as in hypergammaglobulinemia.
###end p 46
###begin title 47
Acknowledgements
###end title 47
###begin p 48
This work was supported in part by grants from The Carlsberg Foundation (H.K.), NIH RO1-EY12712, The Danish National Research Foundation, and The Danish Association for Prevention of Eye Diseases and Blindness.
###end p 48
###begin title 49
References
###end title 49
###begin article-title 50
###xml 76 81 <span type="species:ncbi:9606">human</span>
cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta.
###end article-title 50
###begin article-title 51
###xml 122 127 <span type="species:ncbi:9606">human</span>
Purification and structural characterization of transforming growth factor beta induced protein (TGFBIp) from porcine and human corneas.
###end article-title 51
###begin article-title 52
Identification of motifs for cell adhesion within the repeated domains of transforming growth factor-beta-induced gene, betaig-h3.
###end article-title 52
###begin article-title 53
Betaig-h3 supports keratinocyte adhesion, migration, and proliferation through alpha3beta1 integrin.
###end article-title 53
###begin article-title 54
RGD-CAP ((beta)ig-h3) enhances the spreading of chondrocytes and fibroblasts via integrin alpha(1)beta(1).
###end article-title 54
###begin article-title 55
Identification of motifs in the fasciclin domains of the transforming growth factor-beta-induced matrix protein betaig-h3 that interact with the alphavbeta5 integrin.
###end article-title 55
###begin article-title 56
###xml 90 95 <span type="species:ncbi:9606">human</span>
Transforming growth factor-beta-inducible gene-h3 (beta(ig)-h3) promotes cell adhesion of human astrocytoma cells in vitro: implication of alpha6beta4 integrin.
###end article-title 56
###begin article-title 57
The transforming growth factor-beta-inducible matrix protein (beta)ig-h3 interacts with fibronectin.
###end article-title 57
###begin article-title 58
Characterization of a cartilage-derived 66-kDa protein (RGD-CAP/beta ig-h3) that binds to collagen.
###end article-title 58
###begin article-title 59
Covalent and non-covalent interactions of betaig-h3 with collagen VI. Beta ig-h3 is covalently attached to the amino-terminal region of collagen VI in tissue microfibrils.
###end article-title 59
###begin article-title 60
###xml 10 15 <span type="species:ncbi:9606">human</span>
cDNA from human ocular ciliary epithelium homologous to beta ig-h3 is preferentially expressed as an extracellular protein in the corneal epithelium.
###end article-title 60
###begin article-title 61
###xml 48 53 <span type="species:ncbi:9606">human</span>
Discovery of a novel protein (big-h3) in normal human cornea.
###end article-title 61
###begin article-title 62
Beta IG-H3, a novel secretory protein inducible by transforming growth factor-beta, is present in normal skin and promotes the adhesion and spreading of dermal fibroblasts in vitro.
###end article-title 62
###begin article-title 63
###xml 70 75 <span type="species:ncbi:9606">human</span>
Expression of fibrillins and other microfibril-associated proteins in human bone and osteoblast-like cells.
###end article-title 63
###begin article-title 64
The extracellular matrix protein betaIG-H3 is expressed at myotendinous junctions and supports muscle cell adhesion.
###end article-title 64
###begin article-title 65
###xml 88 91 <span type="species:ncbi:10116">rat</span>
###xml 103 108 <span type="species:ncbi:9606">human</span>
Expression of TGF-beta-induced matrix protein betaig-h3 is up-regulated in the diabetic rat kidney and human proximal tubular epithelial cells treated with high glucose.
###end article-title 65
###begin article-title 66
Kerato-epithelin mutations in four 5q31-linked corneal dystrophies.
###end article-title 66
###begin article-title 67
The molecular genetics of the corneal dystrophies--current status.
###end article-title 67
###begin article-title 68
Transforming growth factor beta induced protein accumulation in granular corneal dystrophy type III (Reis-Bucklers dystrophy). Identification by mass spectrometry in 15 year old two-dimensional protein gels.
###end article-title 68
###begin article-title 69
Two mutations in the TGFBI (BIGH3) gene associated with lattice corneal dystrophy in an extensively studied family.
###end article-title 69
###begin article-title 70
TGFBI gene mutations in corneal dystrophies.
###end article-title 70
###begin article-title 71
Systemic investigation of keratoepithelin deposits in TGFBI/BIGH3-related corneal dystrophy.
###end article-title 71
###begin article-title 72
Microarray studies reveal macrophage-like function of stromal keratocytes in the cornea.
###end article-title 72
###begin article-title 73
Accumulation of beta ig-h3 gene product in corneas with granular dystrophy.
###end article-title 73
###begin article-title 74
###xml 171 180 <span type="species:ncbi:10090">nude mice</span>
beta ig-h3: a transforming growth factor-beta-responsive gene encoding a secreted protein that inhibits cell attachment in vitro and suppresses the growth of CHO cells in nude mice.
###end article-title 74
###begin article-title 75
###xml 13 18 <span type="species:ncbi:9606">human</span>
A dataset of human cornea proteins identified by peptide mass fingerprinting and tandem mass spectrometry.
###end article-title 75
###begin article-title 76
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human cornea proteome: bioinformatic analyses indicate import of plasma proteins into the cornea.
###end article-title 76
###begin article-title 77
Analysis of corneal crystalline deposits in multiple myeloma.
###end article-title 77
###begin article-title 78
Immunotactoid keratopathy: a clinicopathologic case report and a review of reports of corneal involvement in systemic paraproteinemias.
###end article-title 78
###begin article-title 79
Intraepithelial corneal immunoglobulin crystals in IgG-kappa multiple myeloma.
###end article-title 79
###begin article-title 80
Paraproteinemic crystalloidal keratopathy: an ultrastructural study of two cases, including immunoelectron microscopy.
###end article-title 80
###begin article-title 81
Immunoprotein deposition in the cornea.
###end article-title 81
###begin article-title 82
Stability towards alkaline conditions can be engineered into a protein ligand.
###end article-title 82
###begin article-title 83
Evaluation of different linker regions for multimerization and coupling chemistry for immobilization of a proteinaceous affinity ligand.
###end article-title 83
###begin article-title 84
Analysis of protein and peptide mixtures. Evaluation of three sodium dodecyl sulphate-polyacrylamide gel electrophoresis buffer systems.
###end article-title 84
###begin article-title 85
###xml 48 53 <span type="species:ncbi:9606">human</span>
Proteomic analysis of the soluble fraction from human corneal fibroblasts with reference to ocular transparency.
###end article-title 85
###begin article-title 86
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human plasma proteome: history, character, and diagnostic prospects.
###end article-title 86
###begin article-title 87
From the first to the last of the immunoglobulins. Perspectives and prospects.
###end article-title 87
###begin article-title 88
Phenotypes, genotypes and their contribution to understanding keratin function.
###end article-title 88
###begin article-title 89
###xml 30 35 <span type="species:ncbi:9606">human</span>
Keratin filaments of cultured human epidermal cells. Formation of intermolecular disulfide bonds during terminal differentiation.
###end article-title 89
###begin article-title 90
Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
###end article-title 90

